1 active not recruiting, 1 completed, 1 recruiting. 3 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 3 | Active not recruiting 1, Completed 1, Recruiting 1 |
Follow DLBCL: new trials by email Literature Review of DLBCL trials Research Report on DLBCL
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Anti-EBV Autologous TCR-T Cell Injection in Relapsed/Refractory EBV-Positive Lymphoma EBV TCR-T - NK/T-cell Lymphoma, Peripheral T-cell Lymphoma (PTCL) | Early Phase 1 | Recruiting | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 24 | 2025-09-20 | 2025-12-02 |
| Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma 131-I Apamistamab, CAR T-cell - B-ALL, DLBCL | Early Phase 1 | Active not recruiting | Memorial Sloan Kettering Cancer Center | 11 | 2021-02-02 | 2026-11-06 |
| 89Zr-DFO-REGN3767 in PET Scans in People With Diffuse Large B Cell Lymphoma (DLBCL) 89Zr-DFO-REGN3767, PET/CT - Large B-cell Lymphoma, DLBCL | Early Phase 1 | Completed | Memorial Sloan Kettering Cancer Center | 7 | 2020-09-11 | 2025-04-23 |
Lymphoma, Extranodal NK-T-Cell (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, T-Cell, Peripheral (1) · Pyloric Stenosis, Hypertrophic (1)
Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Lymphatic Diseases (2) · Lymphoma (2) · Lymphoma, Non-Hodgkin (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Digestive System Diseases (1) · Gastric Outlet Obstruction (1) · Gastrointestinal Diseases (1) · Lymphoma, B-Cell (1) · Lymphoma, T-Cell (1) · Pyloric Stenosis (1)
Immunotherapy, Adoptive (1) · Positron Emission Tomography Computed Tomography (1)
Memorial Sloan Kettering Cancer Center (2) · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (1)
United States (2) · China (1)
Mark B Geyer, MD (1) · Neeta Pandi-Taskar, MD (1)
PMID 18042692, PMID 19880495, PMID 20671118, PMID 23023715, PMID 23649469, PMID 24142051, PMID 26202875, PMID 26222726, PMID 26353084, PMID 26424652, PMID 27269947, PMID 28911074, PMID 29920566, PMID 33242451, PMID 37781191